Metraipolis › archive › dc_ea93537ae682

Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial — Europe PMC PMID:41896701

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41896701
DOI
10.1111/bju.70261
License (as archived)
solo-consultazione
Archived
2026-11-03T19:57:46.342Z
SHA-256 of the archived text
419b44845bbf120feb8127d1c7ade8f614014cdc4683f051a01c1adf95bdb616
Stable URL of this page
https://metraipolis.com/documento/dc_ea93537ae682

How to cite

Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial — Europe PMC PMID:41896701 — Europe PMC (en), https://europepmc.org/article/MED/41896701 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea93537ae682 (Metraipolis archive dc_ea93537ae682, sha256 419b44845bbf120feb8127d1c7ade8f614014cdc4683f051a01c1adf95bdb616)
BibTeX
@misc{dcea93537ae682,
  title = {Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial — Europe PMC PMID:41896701},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41896701},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea93537ae682; sha256 419b44845bbf120feb8127d1c7ade8f614014cdc4683f051a01c1adf95bdb616},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41896701. Agents can read the archived copy with the MCP tool read_document.